Financials in USD. Standardized financial statements.
A compact view of how Verrica Pharmaceuticals Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $35.58M | $7.57M | $5.12M | $9.03M | $12.00M | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | +370.2% | +47.7% | -43.3% | -24.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $3.44M | $2.74M | $746,000 | $725,000 | $472,000 | $229,000 | $257,199 | $20,294 | $0 | $0 |
| Gross Profit? | $32.14M | $4.83M | $4.38M | $8.31M | $11.53M | -$229,000 | -$257,199 | -$20,294 | $0 | $0 |
| Gross Margin? | +90.3% | +63.8% | +85.4% | +92.0% | +96.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $44.08M | $70.75M | $70.14M | $29.60M | $42.44M | $39.95M | $29.82M | $21.88M | $4.46M | $1.91M |
| Operating Income? | -$11.94M | -$65.92M | -$65.76M | -$21.30M | -$30.91M | -$40.18M | -$30.08M | -$21.88M | -$4.46M | -$1.91M |
| EBITDA? | -$9.36M | -$65.90M | -$62.20M | -$21.60M | -$30.31M | -$39.43M | -$27.95M | -$20.63M | -$4.46M | -$1.91M |
| Income Before Tax | -$17.89M | -$76.58M | -$67.00M | -$24.49M | -$35.08M | -$42.69M | -$28.21M | -$20.65M | -$4.46M | -$1.91M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$17.89M | -$76.58M | -$67.00M | -$24.49M | -$35.08M | -$45.50M | -$28.21M | -$20.65M | -$4.46M | -$1.91M |
| EPS? | $-1.68 | $-14.78 | $-14.78 | $-7.17 | $-12.97 | $-17.08 | $-11.33 | $-8.31 | $-3.80 | $-0.74 |
| Diluted EPS? | $-1.68 | $-14.78 | $-14.78 | $-7.17 | $-12.97 | $-17.08 | $-11.33 | $-8.31 | $-3.80 | $-0.74 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality